In rat models of DCM, for instance, targeted ILK therapy using adenoviral vectors demonstrated a significant reduction in inflammatory cell infiltration, cardiomyocyte degeneration, and overall mortality [112]. Here, ILK is linked to familial dilated cardiomyopathy.